Darrell E. O'Brien
Darrell E. O'Brien publishes mostly in Organic Chemistry, Molecular Biology and Nephrology, on topics such as Synthesis and Characterization of Heterocyclic Compounds, Synthesis and Biological Evaluation and Synthesis and biological activity.
- World rank
- #3,436,760 of 7,710,434 ranked researchers
- Rank in United States
- #964,700 of 1,627,098
- Works
- 37
- Citations
- 730
- Citations per work
- 19.7
What does Darrell E. O'Brien research?
Darrell E. O'Brien's work is mostly in Chemistry (82%), Biochemistry, Genetics and Molecular Biology (10%), Medicine (3%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Physical Sciences3081.6%
- Chemistry3081.6%
- Life Sciences411.0%
- Everything else24.7%
- Health Sciences12.7%
- Medicine12.7%
- 1Organic Chemistry81% of their works
- 2Molecular Biology10% of their works
- 3Nephrology2% of their works
- 4Pharmaceutical Science1% of their works
- 5Infectious Diseases1% of their works
- 6Inorganic Chemistry1% of their works
Research topics
- Synthesis and Characterization of Heterocyclic Compounds
- Synthesis and Biological Evaluation
- Synthesis and biological activity
- Synthesis and Reactions of Organic Compounds
- Quinazolinone synthesis and applications
- Phenothiazines and Benzothiazines Synthesis and Activities
- Chemical Reaction Mechanisms
- Synthesis and Reactivity of Heterocycles
Which keywords describe Darrell E. O'Brien's research?
The keywords of their largest research topics: Synthesis, Biological Evaluation, Heterocycles, Anticancer, Antimicrobial, Heterocyclic Compounds, Anticancer Agents and Medicinal Chemistry.
- Phenothiazines
- Indolizines
- Bioactivity
- Quinazoline
- Vascular Targeting Agents
- Oxazolones
- Quinoxaline
- Antimicrobial Activity
- Drug Discovery
- Medicinal Chemistry
- Heterocyclic Compounds
- Anticancer
- Biological Evaluation
- Synthesis
- Heterocycles
- Antimicrobial
- Anticancer Agents
- Molecular Docking
- Triazines
- Derivatives
- Imidazoles
- Tubulin Inhibitors
- Indirubin
- Acidity Scales
- Biological Activities
- Nucleophilicity
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 26 words, with their numbers
- Synthesis646 topics
- Biological Evaluation474 topics
- Heterocycles352 topics
- Anticancer333 topics
- Antimicrobial333 topics
- Heterocyclic Compounds313 topics
- Anticancer Agents272 topics
- Medicinal Chemistry272 topics
- Molecular Docking262 topics
- Drug Discovery221 topic
- Triazines221 topic
- Antimicrobial Activity182 topics
- Derivatives141 topic
- Quinoxaline141 topic
- Imidazoles131 topic
- Oxazolones131 topic
- Tubulin Inhibitors131 topic
- Vascular Targeting Agents131 topic
- Indirubin71 topic
- Quinazoline71 topic
- Acidity Scales41 topic
- Bioactivity41 topic
- Biological Activities41 topic
- Indolizines41 topic
- Nucleophilicity41 topic
- Phenothiazines41 topic
Where does Darrell E. O'Brien work?
Darrell E. O'Brien's main affiliation in the publication record is MRIGlobal, United States.
How many publications and citations does Darrell E. O'Brien have?
OpenAlex counts 37 works and 730 citations for Darrell E. O'Brien, an h-index of 14, ranking #3,436,760 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Darrell E. O'Brien. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.